Phase I Dose Escalation Clinical Trial of Adenovirus Vector Carrying Osteocalcin Promoter-Driven Herpes Simplex Virus Thymidine Kinase in Localized and Metastatic Hormone-Refractory Prostate Cancer-Reference-Cited by-同舟云学术

Phase I Dose Escalation Clinical Trial of Adenovirus Vector Carrying Osteocalcin Promoter-Driven Herpes Simplex Virus Thymidine Kinase in Localized and Metastatic Hormone-Refractory Prostate Cancer

Published:2003-02-10 Issue:3 Volume:14 Page:227-241
ISSN:1043-0342
Container-title:Human Gene Therapy
language:en
Short-container-title:Human Gene Therapy

Author:

Kubo Hiroyuki¹,Gardner Thomas A.²,Wada Yoshitaka³,Koeneman Kenneth S.⁴,Gotoh Akinobu³,Yang Ling⁴,Kao Chinghai⁵,Lim So Dug⁶,Amin Mahul B.⁶,Yang Hua⁴,Black Margaret E.⁷,Matsubara Shigeji⁸,Nakagawa Masayuki⁹,Gillenwater Jay Y.⁴,Zhau Haiyen E.⁸,Chung Leland W.K.⁸

Affiliation:

1. Molecular Urology and Therapeutics Program, Department of Urology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322; Department of Urology, University of Virginia Health System, Charlottesville, VA 22908

2. Department of Urology, Indiana University Medical Center, Indianapolis, IN 46202; Department of Urology, University of Virginia Health System, Charlottesville, VA 22908

3. Department of Urology, Kobe University School of Medicine, Kobe 650-0017, Japan

4. Department of Urology, University of Virginia Health System, Charlottesville, VA 22908

5. Department of Urology, Indiana University Medical Center, Indianapolis, IN 46202

6. Department of Pathology and Laboratory Medicine, Emory University School of Medicine, Atlanta, GA 30322

7. Department of Pharmaceutical Sciences, Washington State University, Pullman, WA 99164

8. Molecular Urology and Therapeutics Program, Department of Urology, Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA 30322

9. Department of Urology, Faculty of Medicine, Kagoshima University, Kagoshima 890-8506, Japan

Publisher

Mary Ann Liebert Inc

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/10430340360535788

Reference41 articles.

1. Cytopathic effect of in situ gene therapy in prostate cancer

2. Isolation of a Common Receptor for Coxsackie B Viruses and Adenoviruses 2 and 5

3. Creation of drug-specific herpes simplex virus type 1 thymidine kinase mutants for gene therapy.

Cited by 110 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review exploring the fusion of oncolytic viruses and cancer immunotherapy: An innovative strategy in the realm of cancer treatment;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-07

2. Review of Safety Data for Adenovirus 5 as a Delivery Vector for Intratumoral Cancer Gene Therapy;Human Gene Therapy;2023-04-01

3. Mesenchymal stem cell-released oncolytic virus: an innovative strategy for cancer treatment;Cell Communication and Signaling;2023-02-24

4. Gastric Cancer and Viruses: A Fine Line between Friend or Foe;Vaccines;2022-04-13

5. Oncolytic Virotherapy in Peritoneal Metastasis Gastric Cancer: The Challenges and Achievements;Frontiers in Molecular Biosciences;2022-02-28